Renae Walsh

489 total citations
21 papers, 375 citations indexed

About

Renae Walsh is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Renae Walsh has authored 21 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 15 papers in Hepatology and 5 papers in Molecular Biology. Recurrent topics in Renae Walsh's work include Hepatitis B Virus Studies (18 papers), Hepatitis C virus research (15 papers) and Liver Disease Diagnosis and Treatment (9 papers). Renae Walsh is often cited by papers focused on Hepatitis B Virus Studies (18 papers), Hepatitis C virus research (15 papers) and Liver Disease Diagnosis and Treatment (9 papers). Renae Walsh collaborates with scholars based in Australia, United States and United Kingdom. Renae Walsh's co-authors include Stephen Locarnini, Peter Revill, Danni Colledge, Lilly Yuen, Elsdon Storey, Nadia Warner, Hans Netter, George O. Lovrecz, Morten Thaysen‐Andersen and Olan Dolezal and has published in prestigious journals such as Journal of Virology, Brain Research and Journal of Hepatology.

In The Last Decade

Renae Walsh

20 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renae Walsh Australia 12 245 191 122 61 53 21 375
Mio Ohki Japan 8 287 1.2× 207 1.1× 77 0.6× 36 0.6× 64 1.2× 10 384
Lilin Zhong United States 12 204 0.8× 248 1.3× 171 1.4× 40 0.7× 32 0.6× 20 463
K Kitajima Japan 7 185 0.8× 103 0.5× 91 0.7× 91 1.5× 61 1.2× 27 374
Monica Pezzanera Italy 8 378 1.5× 440 2.3× 109 0.9× 82 1.3× 58 1.1× 9 603
Dong-Kyun Ryu South Korea 8 151 0.6× 100 0.5× 97 0.8× 15 0.2× 62 1.2× 10 251
Xiping Zhao China 11 263 1.1× 260 1.4× 55 0.5× 86 1.4× 24 0.5× 20 385
Patricia A. Thibault Canada 14 163 0.7× 87 0.5× 370 3.0× 79 1.3× 108 2.0× 26 601
Erik Lontok United States 5 197 0.8× 215 1.1× 88 0.7× 22 0.4× 197 3.7× 7 415
Laura F. Wetherill United Kingdom 6 127 0.5× 33 0.2× 104 0.9× 93 1.5× 34 0.6× 6 296
Lester Suárez-Amarán Spain 6 85 0.3× 54 0.3× 158 1.3× 26 0.4× 52 1.0× 6 315

Countries citing papers authored by Renae Walsh

Since Specialization
Citations

This map shows the geographic impact of Renae Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renae Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renae Walsh more than expected).

Fields of papers citing papers by Renae Walsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renae Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renae Walsh. The network helps show where Renae Walsh may publish in the future.

Co-authorship network of co-authors of Renae Walsh

This figure shows the co-authorship network connecting the top 25 collaborators of Renae Walsh. A scholar is included among the top collaborators of Renae Walsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renae Walsh. Renae Walsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walsh, Renae, R. Hammond, Carina C. D. Joe, et al.. (2023). Immunogenicity of Wild Type and Mutant Hepatitis B Surface Antigen Virus-like Particles (VLPs) in Mice with Pre-Existing Immunity against the Wild Type Vector. Viruses. 15(2). 313–313. 2 indexed citations
2.
Rubio, Aileen, et al.. (2023). A monoclonal antibody 4G2 exhibits anti-viral activity in mouse models of chronic hepatitis B. Journal of Hepatology. 78. S1164–S1164.
3.
Walsh, Renae, Hans Netter, Rachel Hammond, et al.. (2022). Therapeutic vaccination with CLB-3000 in a mouse model of chronic hepatitis B induces anti-HBs responses associated with functional cure. Journal of Hepatology. 77. S834–S834. 1 indexed citations
4.
Xu, Hui, Stephen Locarnini, Darren Wong, et al.. (2021). Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A. Journal of Hepatology. 76(1). 34–45. 21 indexed citations
5.
Joe, Carina C. D., Sayantani Chatterjee, George O. Lovrecz, et al.. (2020). Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity. Vaccine. 38(22). 3892–3901. 29 indexed citations
6.
Hong, Xupeng, Laurie Luckenbaugh, Renae Walsh, et al.. (2020). Characterization of Hepatitis B Precore/Core-Related Antigens. Journal of Virology. 95(3). 50 indexed citations
7.
Kurtovic, Liriye, Renae Walsh, Carina C. D. Joe, et al.. (2019). Hepatitis B virus-like particles expressing Plasmodium falciparum epitopes induce complement-fixing antibodies against the circumsporozoite protein. Vaccine. 37(12). 1674–1684. 12 indexed citations
8.
Walsh, Renae, R. Hammond, Lilly Yuen, et al.. (2019). Predicting HBsAg clearance in genotype A chronic hepatitis B using HBsAg epitope profiling: A biomarker for functional cure. Liver International. 39(11). 2066–2076. 7 indexed citations
9.
Walsh, Renae, R. Hammond, Kathy Merlock Jackson, et al.. (2018). Effects of SB9200 (Inarigivir) therapy on immune responses in patients with chronic hepatitis B. Journal of Hepatology. 68. S89–S89. 5 indexed citations
10.
Locarnini, SA, K. Jackson, Renae Walsh, et al.. (2018). Inarigivir: a novel RIG-I agonist for chronic hepatitis B. 1 indexed citations
11.
12.
Walsh, Renae, R. Hammond, Lilly Yuen, et al.. (2016). Predicting HBsAg Clearance Responses during ARC-520 RNA Interference (RNAI) Therapy Based on HBsAg Epitope Profile Analysis. Journal of Hepatology. 64(2). S602–S602. 3 indexed citations
13.
Sozzi, Vitina, Renae Walsh, Margaret Littlejohn, et al.. (2016). In Vitro Studies Show that Sequence Variability Contributes to Marked Variation in Hepatitis B Virus Replication, Protein Expression, and Function Observed across Genotypes. Journal of Virology. 90(22). 10054–10064. 39 indexed citations
14.
Walsh, Renae, Morten Thaysen‐Andersen, Mylinh La, et al.. (2015). Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity. Journal of Virology. 89(22). 11312–11322. 32 indexed citations
15.
Shaw, Timothy J., Margaret Littlejohn, Danni Colledge, et al.. (2012). In vitro replication phenotype of a novel (−1G) hepatitis B virus variant associated with HIV co‐infection. Journal of Medical Virology. 84(8). 1166–1176. 10 indexed citations
16.
Walsh, Renae, Peter Revill, Danni Colledge, et al.. (2011). Targeting the hepatitis B virus precore antigen with a novel IgNAR single variable domain intrabody. Virology. 411(1). 132–141. 52 indexed citations
17.
Revill, Peter, et al.. (2009). Bioinformatic analysis of the hepadnavirus e‐antigen and its precursor identifies remarkable sequence conservation in all orthohepadnaviruses. Journal of Medical Virology. 82(1). 104–115. 31 indexed citations
18.
Kelly, Louise, et al.. (2007). INCLUSION FORMATION BY ATAXINS -1, -2, -3, AND -7. International Journal of Neuroscience. 117(9). 1289–1314. 3 indexed citations
19.
Walsh, Renae, et al.. (2005). The roles of proteolysis and nuclear localisation in the toxicity of the polyglutamine diseases. A review. Neurotoxicity Research. 7(1-2). 43–57. 23 indexed citations
20.
Storey, Elsdon, et al.. (2004). Different ataxin-2 antibodies display different immunoreactive profiles. Brain Research. 1027(1-2). 103–116. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mio Ohki Breakdown of academic impact, for papers by Lilin Zhong Breakdown of academic impact, for papers by K Kitajima Breakdown of academic impact, for papers by Monica Pezzanera Breakdown of academic impact, for papers by Dong-Kyun Ryu Breakdown of academic impact, for papers by Xiping Zhao Breakdown of academic impact, for papers by Patricia A. Thibault Breakdown of academic impact, for papers by Erik Lontok Breakdown of academic impact, for papers by Laura F. Wetherill Breakdown of academic impact, for papers by Lester Suárez-Amarán
Rankless by CCL
2026